Langerhans Cell Histiocytosis has emerging NIH research funding with 4 grants totaling $6.2M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Langerhans Cell Histiocytosis. Strongest funded area: Basic Science. Largest gap: Clinical Research.
35 clinical trials registered but no NIH-funded clinical or translational research grants found for Langerhans cell histiocytosis. Trials may be industry-sponsored or funded through non-NIH sources.
8 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for Langerhans cell histiocytosis. Existing research activity suggests this may be a viable area for grant applications.
9 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for Langerhans cell histiocytosis. Existing research activity suggests this may be a viable area for grant applications.
6 publications in Gene Therapy / Novel Therapeutics but no NIH-funded grants found in Translational / Drug Development for Langerhans cell histiocytosis. Existing research activity suggests this may be a viable area for grant applications.
These grants mention Langerhans Cell Histiocytosis as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Track funding opportunities for Langerhans Cell Histiocytosis.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.